Glaxosmithkline Pharma Q1 Results: Net profit rises 8% to Rs 116 crore - The Economic Times
GSK selling $3.45 billion stake in Hindustan Unilever: Report - Times of India
Will GlaxoSmithKline deal be worth it for Unilever?
GlaxoSmithKline Needs More Cash to Catch Up on the Science - Bloomberg
GSK to boost spending power of pharma business post break-up
GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022
GSK delivers FY 2021 reported sales of £34 billion, stable at AER, +5% CER; Total EPS 87.6p -24% AER, -13% CER and Adjusted EPS of 113.2p -2% AER, +9% CER | GSK
GSK India reports Rs 133 crore net profit in quarter four of FY23 - The Economic Times
GSK spins off Haleon in biggest European listing in decade | HealthCare Middle East & Africa Magazine
GSK (LSE:GSK) - Stock Price, News & Analysis - Simply Wall St
GlaxoSmithKline Deal for Tesaro: It's the Wrong Medicine - Bloomberg
GlaxoSmithKline: 30% Undervalued And Spinoff To Drive Growth (NYSE:GSK) | Seeking Alpha
GSK plc - Wikipedia
Financial Ratio Analysis of AstraZeneca and GlaxoSmithKline
GlaxoSmithKline Pharma Q2 net up 3% to Rs 193 cr, revenue down to Rs 906 cr
Why GSK should turn down Unilever's billions | MoneyWeek
GSK India reports Rs 133 crore net profit in quarter four of FY23 - The Economic Times
GSK to buy Bellus for $2 billion to gain cough medicine - Times of India
GSK's Emma Walmsley becomes highest-paid female FTSE 100 chief | GlaxoSmithKline | The Guardian
GSK plc - Wikipedia
GlaxoSmithKline revels in £8.8bn profit ahead of consumer healthcare demerger
GSK lines up Rs 6,400cr open offer - Times of India
GSK Pharmaceuticals India: net assets 2022 | Statista
First female CEO of GSK to be paid 25% less than her male predecessor
GSK to buy US biotech group Affinivax in $3bn deal | Financial Times
